review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7 |
P698 | PubMed publication ID | 10685067 |
P2093 | author name string | Schaper W | |
Buschmann I | |||
P2860 | cites work | Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. | Q22008760 |
Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death | Q28510984 | ||
Mechanisms of angiogenesis | Q29547485 | ||
Vascular remodeling and altered protein expression during growth of coronary collateral arteries | Q31918089 | ||
Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery | Q32167243 | ||
Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization | Q33783009 | ||
Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. | Q34722375 | ||
Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium | Q35265510 | ||
Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. | Q35753630 | ||
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb | Q37376876 | ||
The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow | Q37381694 | ||
Genetic analysis of blood vessel formation role of endothelial versus smooth muscle cells | Q37828670 | ||
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb | Q39425647 | ||
The effects of rhGM-CSF on macrophage function | Q40858798 | ||
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT | Q41954036 | ||
Vascular development and disorders: molecular analysis and pathogenic insights | Q45887379 | ||
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border | Q47964362 | ||
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas | Q48132844 | ||
Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct | Q48182992 | ||
Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF | Q59071080 | ||
P433 | issue | 3 | |
P921 | main subject | pathophysiology | Q1135939 |
P304 | page(s) | 338-342 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | The pathophysiology of the collateral circulation (arteriogenesis). | |
P478 | volume | 190 |
Q43212698 | A non-parametric vessel detection method for complex vascular structures |
Q35880859 | Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brain |
Q52846283 | Acute physical exercise and long-term individual shear rate therapy increase telomerase activity in human peripheral blood mononuclear cells. |
Q45858511 | Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb |
Q46267019 | Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training |
Q46792558 | Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery |
Q34534186 | An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. |
Q27861015 | Angiogenesis in cancer and other diseases |
Q93052664 | Association between Vascular Endothelial Growth Factor Plasma Levels and rs699947 Polymorphism and Coronary Collateral Vessel Formation |
Q37951953 | Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. |
Q36067853 | CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction |
Q97526732 | Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine |
Q41813965 | Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. |
Q42562382 | Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke |
Q37600928 | Chronic total artery occlusions in noninfarct-related coronary arteries. |
Q45878227 | Clinical efforts to modulate angiogenesis in the adult: gene therapy versus conventional approaches |
Q34315287 | Collateralization and the response to obstruction of epicardial coronary arteries |
Q36420148 | Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome |
Q28392278 | Diesel exhaust exposure induces angiogenesis |
Q36898800 | Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. |
Q49042138 | Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion |
Q28570673 | Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells |
Q90475042 | Endothelial Progenitor Cells in Moyamoya Disease: Current Situation and Controversial Issues |
Q35121798 | Fluid shear stress and the vascular endothelium: for better and for worse |
Q35218706 | Gene-based therapeutic angiogenesis |
Q34588764 | HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia |
Q37594746 | Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. |
Q60182332 | High blood pressure is inversely related with the presence and extent of coronary collaterals |
Q36811199 | Imaging of angiogenesis in cardiology |
Q49131272 | Induction of cerebral arteriogenesis leads to early-phase expression of protease inhibitors in growing collaterals of the brain |
Q28572517 | Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia |
Q73081651 | Invasive and non-invasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease |
Q73299565 | Is There Functional Collateral Flow During Vascular Occlusion in Angiographically Normal Coronary Arteries? |
Q52561272 | MicroRNA expression profile and functional analysis reveal their roles in contact inhibition and its disruption switch of rat vascular smooth muscle cells. |
Q36908997 | Modulating the vascular response to limb ischemia: angiogenic and cell therapies. |
Q35551132 | Molecular basis of angiogenesis and cancer |
Q33813333 | Neurorestorative therapy for stroke |
Q92677852 | Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling |
Q26827707 | Pathophysiology of coronary collaterals |
Q39381435 | Perpetual change: autophagy, the endothelium, and response to vascular injury |
Q93271523 | Perspectives on Using Platelet-Rich Plasma and Platelet-Rich Fibrin for Managing Patients with Critical Lower Limb Ischemia After Partial Foot Amputation |
Q58778121 | Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes |
Q34700750 | Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. |
Q33402912 | Quantitative analysis of peripheral tissue perfusion using spatiotemporal molecular dynamics |
Q47094282 | Reduced Gja5 expression in arterial endothelial cells impairs arteriogenesis during acute ischemic cardiovascular disease |
Q34959073 | Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. |
Q37344734 | Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice |
Q41984687 | Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke |
Q44646897 | Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. |
Q92081350 | Sustained Release of Basic Fibroblast Growth Factor (bFGF) Encapsulated Polycaprolactone (PCL) Microspheres Promote Angiogenesis In Vivo |
Q34500561 | TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways |
Q42588233 | TNF-alpha and shear stress-induced large artery adaptations |
Q26798071 | The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity |
Q26753079 | The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease |
Q47680208 | The relation between chronic obstructive pulmonary disease and coronary collateral vessels |
Q24799337 | Therapeutic angiogenesis for cardiovascular disease |
Q78822731 | Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model |
Q35080395 | Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review |
Q35534183 | Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis. |
Q37405822 | Training-induced vascular adaptations to ischemic muscle. |
Q44590707 | Transcriptional and post‐translation regulation of the Tiel receptor by fluid shear stress changes in vascular endothelial cells |
Q47420526 | Translesional pressure gradient and leptomeningeal collateral status in symptomatic middle cerebral artery stenosis. |
Q52000318 | Vascular cells. |
Q34481171 | Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis |
Q81450014 | [Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis] |
Search more.